Multiple Myeloma and the Immune Microenvironment
Journal:
Current Cancer Drug Targets
Volume:
17
Page:
806-818
Author(s):
Yawara Kawano, Aldo. M. Roccaro, Irene M. Ghobrial* and Jamil Azzi*
Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases
Journal:
Current Drug Safety
Volume:
12
Page:
162-170
Author(s):
Rui Pereira, Raquel Faria, Paula Lago and Tiago Torres*
Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1328-1343
Author(s):
Marta Colletti, Virginia Di Paolo, Angela Galardi, Giuseppe Maria Milano, Angela Mastronuzzi, Franco Locatelli and Angela Di Giannatale*
Major Highlights of the CAR-TCR Summit, Boston, 2016
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1344-1350
Author(s):
Vita Golubovskaya*, Robert Berahovich, Shirley Xu, Hizkia Harto and Lijun Wu*
Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
3025-3053
Author(s):
Agnieszka Dreas, Maciej Mikulski, Mariusz Milik, Charles-Henry Fabritius, Krzysztof Brzózka and Tomasz Rzymski*
Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release
Journal:
Current Topics in Medicinal Chemistry
Volume:
17
Page:
2849-2865
Author(s):
Jiao Feng, Sinda Lepetre-Mouelhi * and Patrick Couvreur
Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1211-1227
Author(s):
Padmanabhan Rengasamy*
Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1267-1277
Author(s):
Ximena Camacho, Camila Longo Machado, Maria Fernanda García, Marcelo Fernández, Natalia Oddone, Juan Benech, Juan Pablo Gambini, Hugo Cerecetto, Roger Chammas, Pablo Cabral and Eloisa Riva*
Immune Checkpoints Aberrations and Malignant Mesothelioma: Assessment of Prognostic Value and Evaluation of Therapeutic Potentials
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1228-1233
Author(s):
Hadeer Mohamed, Mostafa Eltobgy and Omar Abdel-Rahman*
The Breakthroughs in Cancer Immune Checkpoint Based Therapy: A Review of Development in Immune Checkpoint Study and its Application
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
20
Page:
430-439
Author(s):
Yao Huang, Dong Liang, Jingfeng Liu, Jinhua Zeng and Yongyi Zeng*